In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Cosmetics, Colors Office Director Katz Joins From OTC Division

This article was originally published in The Rose Sheet

Executive Summary

FDA's Office of Cosmetics and Colors will be headed by OTC drugs division Deputy Director Linda Katz, MD, on a permanent basis, the Center for Food Safety and Applied Nutrition has announced. The appointment is effective Sept. 3

You may also be interested in...



Office Of Cosmetics & Colors 2003 Priorities Highlight Program Revitalization

Developing a plan to revitalize FDA's Office of Cosmetics & Colors is a top priority for the program this year, Center for Food Safety & Applied Nutrition Director Joseph Levitt announced during a press briefing in College Park, Md. March 10

Office Of Cosmetics & Colors 2003 Priorities Highlight Program Revitalization

Developing a plan to revitalize FDA's Office of Cosmetics & Colors is a top priority for the program this year, Center for Food Safety & Applied Nutrition Director Joseph Levitt announced during a press briefing in College Park, Md. March 10

Colored Contact Lens Deregulation Lacks Precedent – Rep. Waxman

FDA's consideration of an industry proposal to reclassify colored noncorrective contact lenses as cosmetics is not justified due to case history proving the agency can regulate products on grounds other than marketing claims, according to House Government Reform Committee Ranking Member Henry Waxman (D-Calif.)

Related Content

UsernamePublicRestriction

Register

LL055695

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel